Read about the 2025 International Genetic Epidemiology Society conference and learn why genomics research is entering a new era.

San Francisco, CA — 23andMe, once a pioneer in direct-to-consumer (DTC) genetic testing and a recognized player in AI-driven health data, has filed for Chapter 11 bankruptcy protection, marking a significant turning point for both the company and the broader digital health industry. The filing, confirmed this week, comes amid declining sales, increased competition, and growing consumer wariness around data privacy in the genomics space. Founded in 2006, 23andMe gained global attention for democratizing access to personal genetic information, offering consumers ancestry insights and health risk reports with a simple saliva test.

Integrate cutting-edge LLM technology quickly and easily into your apps - microsoft/semantic-kernel

Using artificial intelligence, researchers at Stanford now have uncovered complex variants throughout the human genome that may contribute to psychiatric disorders.